Opioid Analgesic Market Report: Trends, Forecast and Competitive Analysis to 2030
Get it in 2 to 4 weeks by ordering today
Opioid Analgesic Trends and Forecast
The future of the global opioid analgesic market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets. The global opioid analgesic market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing need for pain treatment following surgery, improvements in medication formulations to reduce the negative effects of analgesics, as well as, increasing rates of orthopedic diseases and persistent pain in the elderly.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Opioid Analgesic by Segment
The study includes a forecast for the global opioid analgesic by drug class, indication, route of administration, end use, and region.
Opioid Analgesic Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies opioid analgesic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the opioid analgesic companies profiled in this report include-
Lucintel forecasts that oral is expected to witness the highest growth over the forecast period because it is the most practical and economical method of administering opioid analgesics.
North America is expected to witness highest growth over the forecast period.
Features of the Global Opioid Analgesic Market
Market Size Estimates: Opioid analgesic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Opioid analgesic market size by drug class, indication, route of administration, end use, and region in terms of value ($B).
Regional Analysis: Opioid analgesic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug class, indication, route of administration, end use, and regions for the opioid analgesic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the opioid analgesic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for opioid analgesic market?
Answer: The global opioid analgesic market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the opioid analgesic market?
Answer: The major drivers for this market are growing need for pain treatment following surgery, improvements in medication formulations to reduce the negative effects of analgesics, as well as, increasing rates of orthopedic diseases and persistent pain in the elderly.
Q3. What are the major segments for opioid analgesic market?
Answer: The future of the global opioid analgesic market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets.
Q4. Who are the key opioid analgesic market companies?
Answer: Some of the key opioid analgesic companies are as follows:
Answer: Lucintel forecasts that oral is expected to witness the highest growth over the forecast period because it is the most practical and economical method of administering opioid analgesics.
Q6. In opioid analgesic market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.7 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the opioid analgesic market by drug class (morphine, codeine, fentanyl, meperidine, methadone, tramadol, oxycodone, dextromethorphan, buprenorphine, and others), indication (surgical pain, cancer pain, neuropathic pain, and others), route of administration (oral, parenteral, transdermal, and others), end use (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Opioid Analgesic Market, Opioid Analgesic Market Size, Opioid Analgesic Market Growth, Opioid Analgesic Market Analysis, Opioid Analgesic Market Report, Opioid Analgesic Market Share, Opioid Analgesic Market Trends, Opioid Analgesic Market Forecast, Opioid Analgesic Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Opioid Analgesic Trends and Forecast
The future of the global opioid analgesic market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets. The global opioid analgesic market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing need for pain treatment following surgery, improvements in medication formulations to reduce the negative effects of analgesics, as well as, increasing rates of orthopedic diseases and persistent pain in the elderly.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Opioid Analgesic by Segment
The study includes a forecast for the global opioid analgesic by drug class, indication, route of administration, end use, and region.
Opioid Analgesic Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Tramadol
- Oxycodone
- Dextromethorphan
- Buprenorphine
- Others
- Surgical Pain
- Cancer Pain
- Neuropathic Pain
- Others
- Oral
- Parenteral
- Transdermal
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies opioid analgesic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the opioid analgesic companies profiled in this report include-
- Pfizer
- Abbott Laboratories
- Janssen Pharmaceuticals
- Novartis
- Bayer
- GlaxoSmithKline
- F. Hoffmann-La Roche
- Boehringer Ingelheim
- Bausch
- Sanofi
Lucintel forecasts that oral is expected to witness the highest growth over the forecast period because it is the most practical and economical method of administering opioid analgesics.
North America is expected to witness highest growth over the forecast period.
Features of the Global Opioid Analgesic Market
Market Size Estimates: Opioid analgesic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Opioid analgesic market size by drug class, indication, route of administration, end use, and region in terms of value ($B).
Regional Analysis: Opioid analgesic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug class, indication, route of administration, end use, and regions for the opioid analgesic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the opioid analgesic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for opioid analgesic market?
Answer: The global opioid analgesic market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the opioid analgesic market?
Answer: The major drivers for this market are growing need for pain treatment following surgery, improvements in medication formulations to reduce the negative effects of analgesics, as well as, increasing rates of orthopedic diseases and persistent pain in the elderly.
Q3. What are the major segments for opioid analgesic market?
Answer: The future of the global opioid analgesic market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets.
Q4. Who are the key opioid analgesic market companies?
Answer: Some of the key opioid analgesic companies are as follows:
- Pfizer
- Abbott Laboratories
- Janssen Pharmaceuticals
- Novartis
- Bayer
- GlaxoSmithKline
- F. Hoffmann-La Roche
- Boehringer Ingelheim
- Bausch
- Sanofi
Answer: Lucintel forecasts that oral is expected to witness the highest growth over the forecast period because it is the most practical and economical method of administering opioid analgesics.
Q6. In opioid analgesic market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.7 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the opioid analgesic market by drug class (morphine, codeine, fentanyl, meperidine, methadone, tramadol, oxycodone, dextromethorphan, buprenorphine, and others), indication (surgical pain, cancer pain, neuropathic pain, and others), route of administration (oral, parenteral, transdermal, and others), end use (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Opioid Analgesic Market, Opioid Analgesic Market Size, Opioid Analgesic Market Growth, Opioid Analgesic Market Analysis, Opioid Analgesic Market Report, Opioid Analgesic Market Share, Opioid Analgesic Market Trends, Opioid Analgesic Market Forecast, Opioid Analgesic Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL OPIOID ANALGESIC MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Opioid Analgesic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Opioid Analgesic Market by Drug Class
3.3.1: Morphine
3.3.2: Codeine
3.3.3: Fentanyl
3.3.4: Meperidine
3.3.5: Methadone
3.3.6: Tramadol
3.3.7: Oxycodone
3.3.8: Dextromethorphan
3.3.9: Buprenorphine
3.4: Global Opioid Analgesic Market by Indication
3.4.1: Surgical Pain
3.4.2: Cancer Pain
3.4.3: Neuropathic Pain
3.4.4: Others
3.5: Global Opioid Analgesic Market by Route of Administration
3.5.1: Oral
3.5.2: Parenteral
3.5.3: Transdermal
3.5.4: Others
3.6: Global Opioid Analgesic Market by End Use
3.6.1: Hospital Pharmacies
3.6.2: Retail Pharmacies
3.6.3: Drug Stores
3.6.4: Online Pharmacies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Opioid Analgesic Market by Region
4.2: North American Opioid Analgesic Market
4.2.1: North American Opioid Analgesic Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
4.2.2: North American Opioid Analgesic Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
4.3: European Opioid Analgesic Market
4.3.1: European Opioid Analgesic Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
4.3.2: European Opioid Analgesic Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
4.4: APAC Opioid Analgesic Market
4.4.1: APAC Opioid Analgesic Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
4.4.2: APAC Opioid Analgesic Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
4.5: ROW Opioid Analgesic Market
4.5.1: ROW Opioid Analgesic Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
4.5.2: ROW Opioid Analgesic Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Opioid Analgesic Market by Drug Class
6.1.2: Growth Opportunities for the Global Opioid Analgesic Market by Indication
6.1.3: Growth Opportunities for the Global Opioid Analgesic Market by Route of Administration
6.1.4: Growth Opportunities for the Global Opioid Analgesic Market by End Use
6.1.5: Growth Opportunities for the Global Opioid Analgesic Market by Region
6.2: Emerging Trends in the Global Opioid Analgesic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Opioid Analgesic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Opioid Analgesic Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Pfizer
7.2: Abbott Laboratories
7.3: Janssen Pharmaceuticals
7.4: Novartis
7.5: Bayer
7.6: GlaxoSmithKline
7.7: F. Hoffmann-La Roche
7.8: Boehringer Ingelheim
7.9: Bausch
7.10: Sanofi
2. GLOBAL OPIOID ANALGESIC MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Opioid Analgesic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Opioid Analgesic Market by Drug Class
3.3.1: Morphine
3.3.2: Codeine
3.3.3: Fentanyl
3.3.4: Meperidine
3.3.5: Methadone
3.3.6: Tramadol
3.3.7: Oxycodone
3.3.8: Dextromethorphan
3.3.9: Buprenorphine
3.4: Global Opioid Analgesic Market by Indication
3.4.1: Surgical Pain
3.4.2: Cancer Pain
3.4.3: Neuropathic Pain
3.4.4: Others
3.5: Global Opioid Analgesic Market by Route of Administration
3.5.1: Oral
3.5.2: Parenteral
3.5.3: Transdermal
3.5.4: Others
3.6: Global Opioid Analgesic Market by End Use
3.6.1: Hospital Pharmacies
3.6.2: Retail Pharmacies
3.6.3: Drug Stores
3.6.4: Online Pharmacies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Opioid Analgesic Market by Region
4.2: North American Opioid Analgesic Market
4.2.1: North American Opioid Analgesic Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
4.2.2: North American Opioid Analgesic Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
4.3: European Opioid Analgesic Market
4.3.1: European Opioid Analgesic Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
4.3.2: European Opioid Analgesic Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
4.4: APAC Opioid Analgesic Market
4.4.1: APAC Opioid Analgesic Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
4.4.2: APAC Opioid Analgesic Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
4.5: ROW Opioid Analgesic Market
4.5.1: ROW Opioid Analgesic Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
4.5.2: ROW Opioid Analgesic Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Opioid Analgesic Market by Drug Class
6.1.2: Growth Opportunities for the Global Opioid Analgesic Market by Indication
6.1.3: Growth Opportunities for the Global Opioid Analgesic Market by Route of Administration
6.1.4: Growth Opportunities for the Global Opioid Analgesic Market by End Use
6.1.5: Growth Opportunities for the Global Opioid Analgesic Market by Region
6.2: Emerging Trends in the Global Opioid Analgesic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Opioid Analgesic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Opioid Analgesic Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Pfizer
7.2: Abbott Laboratories
7.3: Janssen Pharmaceuticals
7.4: Novartis
7.5: Bayer
7.6: GlaxoSmithKline
7.7: F. Hoffmann-La Roche
7.8: Boehringer Ingelheim
7.9: Bausch
7.10: Sanofi
